Enabling Tissue- & Cell-Specific mRNA Delivery with Cell-Penetrating Peptide-Based Hybrid Nanosystems
11:00 am - Friday 19th February 2027
- Optimising cell-penetrating peptides and hybrid nanoparticle- RNA interactions to achieve stable complexation, cellular uptake & intracellular cargo release
- Engineering peptide-based systems for selective delivery to specific tissues or cell populations
- Comparing targeting performance, tolerability, scalability & manufacturability against established LNP platforms
- Identifying applications where alternative delivery vehicles can provide a meaningful targeting or therapeutic advantage over LNPs
